Trials Sponsors Conditions Drugs Pricing

Conditions

Pancreatic Cancer

Keywords

Metastatic

Interventions

PANVAC™-VFBiological

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Patients \> 18 years of age who have been vaccinated against smallpox;
Histologically confirmed diagnosis of adenocarcinoma of the pancreas;

Sponsors & Collaborators

Therion Biologics Corporation
Industrylead

Study Sites (62)

University of South Alabama/ Cancer Research Institute

Mobile, Alabama, 36693, United States

Moores UCSD Cancer Center

La Jolla, California, 92093, United States

Pacific Shores Medical Group

Long Beach, California, 90813, United States

USC/Norris Comprehensive Cancer Center

Los Angeles, California, 90033, United States

Chao Family Comprehensice Cancer Center

Orange, California, 92868, United States

Desert Hematology Oncology Medical Group, Inc

Rancho Mirage, California, 92270, United States

Scripps Cancer Center

MeSH Terms

Conditions

Pancreatic NeoplasmsNeoplasm Metastasis

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type: interventional
Phase: phase 3
Allocation: RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

July 30, 2004

First Posted

August 2, 2004

Study Start

June 2004

Date type not reported

This date has not been verified as actual or estimated.

Last Updated

February 8, 2006

Record last verified: 2006-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00088660
Data provider: ClinicalTrials.gov
Source updated: 2006-02-08
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:34:30 UTC

PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (62)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record

You may not qualify if:

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (62)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record

You may not qualify if:

Locations